AzTrials
AzTrials

Acute Compartment SyndromeNCT05030259

The Research About the ACS After Femoropopliteal Arterial Injuries

An observational study of Acute Compartment Syndrome, run by Hebei Medical University Third Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Crural Compartment syndrome is a well-known sequela after femoropopliteal arterial injuries in the lower extremity, particularly when there has been a long period of ischemia,need for ligation of a major vein, or when there is severe associated soft tissue.There is conteoversy in the treatment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Compartment Syndrome
What is being tested?
fasciotomy
Type of treatment
Surgery or procedure
How many people
80 participants
Where
1 siteChina
Study dates
1 Sep 2021to 31 Dec 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The patients with femoropopliteal arterial injuries in our hospital who will be treated with vascular repair.

Who may be able to join

  • patients with femoropopliteal arterial injuries
  • patients older than 18 years

Who cannot join

  • Patients who did not survive to discharge
  • Patients with primary amputation
  • patients younger than 18 years

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Guo Jialiang, Doctor contact

18203222090

drjlguo86@gmail.com

China1 site, 1 recruiting
  • the Third Hospital of Hebei Medical Univesity

    Shijiazhuang, Hebei, 050000

    Sun Changsheng, 15176139310, 15176139310@163.com

    Recruiting

Other trials in China

About this study

Official title: ACS After Femoropopliteal Arterial Injuries

Crural Compartment syndrome is a well-known sequela after femoropopliteal arterial injuries in the lower extremity, particularly when there has been a long period of ischemia,need for ligation of a major vein, or when there is severe associated soft tissue.There is conteoversy in the treatment.

Being tested
fasciotomy
Keywords
ACS, femoropopliteal arterial injuries, fasciotomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fasciotomyProcedure or surgery

    To perform fasciotomy

Study groups in NCT05030259
Study groupRoleWhat they receive
patients with fasciotomyNot described
Receives: Procedure: fasciotomy
patients without fasciotomyNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the rate of amputation

    Measured: up to 6 months

  2. fasciotomy performed or not

    Measured: up to 2 weeks

Secondary outcomes (26)
  1. the rate of primary skin closure

    Measured: up to 1 months

  2. hospital lengths of stay

    Measured: up to 6 months

  3. injury mechanism of patients

    Measured: up to 1 week

  4. the costs of hospitalization

    Measured: up to 2 months

  5. tourniquet used or not

    Measured: up to 1 week

  6. the time of using tourniquet

    Measured: up to 1 week

  7. the time to surgical intervention

    Measured: up to 1 month

  8. extremity Abbreviated Injury Scale of patients

    minimum is 1, maximum is 6, higher scores mean a worse outcome

    Measured: up to 1 week

  9. Injury Severity Score of patients

    minimum is 0, maximum is 75, higher scores mean a worse outcome

    Measured: up to 1 week

  10. concomitant injury of patients

    Measured: up to 1 week

  11. time of skin closure

    Measured: up to 1 month

  12. admission hemoglobin of patients

    Measured: up to 1 month

  13. admission pH of patients

    Measured: up to 1 month

  14. admission lactate of patients

    Measured: up to 1 month

  15. postoperative lactate of patients

    Measured: up to 1 month

  16. admission International Normalized Ratio of patients

    Measured: up to 1 month

  17. postoperative International Normalized Ratio of patients

    Measured: up to 1 month

  18. admission CK of patients

    Measured: up to 1 month

  19. postoperative CK of patients

    Measured: up to 1 month

  20. admission LDH of patients

    Measured: up to 1 month

  21. postoperative LDH of patients

    Measured: up to 1 month

  22. Number of Participants with Lower Extremity Arteriosclerosis Obliterans

    Measured: up to 1 week

  23. vascular repair technique of patients

    Measured: up to 1 week

  24. Number of Participants with sepsis

    Measured: up to 1 month

  25. Ischemia time of patients

    Measured: up to 1 week

  26. Postoperative knee function of patients

    Measured: up to 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2021
  2. Study start1 Sep 2021 (estimated)
  3. Primary completion1 Dec 2023 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05030259
Sponsor's protocol ID
HZY005ACS
Status last verified
Aug 2021
First submitted
3 Aug 2021
Last updated
1 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: acute compartment syndrome

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Compartment Syndrome, run by Hebei Medical University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Guo Jialiang, Doctor (18203222090, drjlguo86@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the rate of amputation (time frame: up to 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in